SUPN:NASDAQ
Supernus, Inc.
$36.28
0.00%
(0.00) 1D
$36.41
arrow_upward
+0.36% (+0.13)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SUPN...
Mkt. cap
5.99B
Avg. vol.
2.44M
Volume
0.00
P/E ratio
13.06
52-wk high
$42.81
52-wk low
$27.68
EPS
$2.78
Beta
1.10
Shares outstanding
118.04M
No. of employees
778
Mkt. cap
5.99B
Avg. vol.
2.44M
Volume
0.00
P/E ratio
13.06
52-wk high
$42.81
52-wk low
$27.68
EPS
$2.78
Beta
1.10
Shares outstanding
118.04M
No. of employees
778
News stories
From web sources and news partners
Investing.com
·
20 hours ago
Supernus at jefferies global healthcare conference: merger boosts scale
Profile
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
About Supernus, Inc.
CEOJack A. Khattar | Mark Crossley
Employees778
FoundedSep 26, 2014
HeadquartersRockville, Maryland, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteindivior.com